(VSCO) Victoria's Secret - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9264001028
Stock: Bras, Lingerie, Panties, Sleepwear, Fragrance
Total Rating 58
Risk 63
Buy Signal -0.25
| Risk 5d forecast | |
|---|---|
| Volatility | 63.8% |
| Relative Tail Risk | -6.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.63 |
| Alpha | 114.41 |
| Character TTM | |
|---|---|
| Beta | 2.697 |
| Beta Downside | 2.370 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.47% |
| CAGR/Max DD | 0.20 |
EPS (Earnings per Share)
Revenue
Description: VSCO Victoria's Secret March 03, 2026
Victoria’s Secret & Co. (NYSE: VSCO) is a specialty retailer that sells women’s intimate apparel, sleepwear, loungewear, activewear, swimwear, and beauty products under the Victoria’s Secret, PINK and Adore Me brands. Its distribution mix includes company-owned stores, franchise and licensing partners, and a growing suite of e-commerce sites such as VictoriasSecret.com, PINK.com, AdoreMe.com and DailyLook.com.
Key recent metrics show the business is rebounding: FY 2024 same-store sales rose 6.2% YoY, while digital sales grew 14% as the company expands its omnichannel footprint. Gross margin improved to 38.5% after cost-saving initiatives, and the firm reported a 2024 Q2 adjusted EBITDA of $112 million, reflecting stronger brand positioning amid a consumer-discretionary environment supported by stabilising inflation and modest wage growth.
For deeper valuation insights, you might explore ValueRay’s analysis of VSCO.
Headlines to watch out for
- Intimate apparel sales drive core revenue growth
- Digital channel expansion boosts online sales penetration
- Supply chain costs impact merchandise profitability
- Consumer discretionary spending influences product demand
- Brand perception shifts affect market share
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 160.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.53 > 1.0 |
| NWC/Revenue: 6.93% < 20% (prev 1.06%; Δ 5.87% < -1%) |
| CFO/TA 0.10 > 3% & CFO 500.0m > Net Income 160.9m |
| Net Debt (4.74b) to EBITDA (460.1m): 10.30 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.8m) vs 12m ago 3.25% < -2% |
| Gross Margin: 36.38% > 18% (prev 0.37%; Δ 3.60k% > 0.5%) |
| Asset Turnover: 135.6% > 50% (prev 137.4%; Δ -1.84% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBITDA TTM 460.1m / Interest Expense TTM 69.7m) |
Altman Z'' 0.85
| A: 0.09 (Total Current Assets 1.95b - Total Current Liabilities 1.49b) / Total Assets 5.13b |
| B: 0.06 (Retained Earnings 320.0m / Total Assets 5.13b) |
| C: 0.01 (EBIT TTM 46.1m / Avg Total Assets 4.83b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 4.45b) |
| Altman-Z'' Score: 0.85 = B |
Beneish M
| DSRI: none (Receivables none/159.0m, Revenue 6.55b/6.23b) |
| GMI: 1.01 (GM 36.38% / 36.65%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.05 (Revenue 6.55b / 6.23b) |
| TATA: -0.07 (NI 160.9m - CFO 500.0m) / TA 5.13b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of VSCO shares?
As of March 16, 2026, the stock is trading at USD 44.86 with a total of 1,826,731 shares traded.
Over the past week, the price has changed by -6.77%, over one month by -25.68%, over three months by -18.08% and over the past year by +123.63%.
Over the past week, the price has changed by -6.77%, over one month by -25.68%, over three months by -18.08% and over the past year by +123.63%.
Is VSCO a buy, sell or hold?
Victoria's Secret has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold VSCO.
- StrongBuy: 1
- Buy: 2
- Hold: 5
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the VSCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65.3 | 45.6% |
| Analysts Target Price | 65.3 | 45.6% |
VSCO Fundamental Data Overview March 16, 2026
P/E Trailing = 21.061
P/E Forward = 16.9492
P/S = 0.5495
P/B = 5.5143
Revenue TTM = 6.55b USD
EBIT TTM = 46.1m USD
EBITDA TTM = 460.1m USD
Long Term Debt = 1.35b USD (from longTermDebt, two quarters ago)
Short Term Debt = 288.0m USD (from shortTermDebt, two quarters ago)
Debt = 4.74b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 4.74b USD (using Total Debt 4.74b, CCE unavailable)
Enterprise Value = 8.34b USD (3.60b + Debt 4.74b - (null CCE))
Interest Coverage Ratio = 0.66 (Ebit TTM 46.1m / Interest Expense TTM 69.7m)
EV/FCF = 26.98x (Enterprise Value 8.34b / FCF TTM 309.0m)
FCF Yield = 3.71% (FCF TTM 309.0m / Enterprise Value 8.34b)
FCF Margin = 4.71% (FCF TTM 309.0m / Revenue TTM 6.55b)
Net Margin = 2.45% (Net Income TTM 160.9m / Revenue TTM 6.55b)
Gross Margin = 36.38% ((Revenue TTM 6.55b - Cost of Revenue TTM 4.17b) / Revenue TTM)
Gross Margin QoQ = 37.67% (prev 36.41%)
Tobins Q-Ratio = 1.62 (Enterprise Value 8.34b / Total Assets 5.13b)
Interest Expense / Debt = 0.35% (Interest Expense 16.8m / Debt 4.74b)
Taxrate = 7.42% (16.0m / 215.4m)
NOPAT = 42.7m (EBIT 46.1m * (1 - 7.42%))
Current Ratio = 1.30 (Total Current Assets 1.95b / Total Current Liabilities 1.49b)
Debt / Equity = 7.25 (Debt 4.74b / totalStockholderEquity, two quarters ago 653.0m)
Debt / EBITDA = 10.30 (Net Debt 4.74b / EBITDA 460.1m)
Debt / FCF = 15.33 (Net Debt 4.74b / FCF TTM 309.0m)
Total Stockholder Equity = 654.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.33% (Net Income 160.9m / Total Assets 5.13b)
RoE = 24.58% (Net Income TTM 160.9m / Total Stockholder Equity 654.5m)
RoCE = 2.30% (EBIT 46.1m / Capital Employed (Equity 654.5m + L.T.Debt 1.35b))
RoIC = 2.34% (NOPAT 42.7m / Invested Capital 1.82b)
WACC = 7.03% (E(3.60b)/V(8.34b) * Re(15.85%) + D(4.74b)/V(8.34b) * Rd(0.35%) * (1-Tc(0.07)))
Discount Rate = 15.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.25%
[DCF] Terminal Value 80.47% ; FCFF base≈248.6m ; Y1≈225.7m ; Y5≈197.0m
[DCF] Fair Price = N/A (negative equity: EV 4.34b - Net Debt 4.74b = -396.1m; debt exceeds intrinsic value)
EPS Correlation: -8.04 | EPS CAGR: 27.62% | SUE: 1.96 | # QB: 3
Revenue Correlation: 21.32 | Revenue CAGR: 12.00% | SUE: 1.36 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.32 | Chg7d=+0.232 | Chg30d=+0.232 | Revisions Net=+7 | Analysts=9
EPS current Year (2027-01-31): EPS=3.47 | Chg7d=+0.425 | Chg30d=+0.447 | Revisions Net=+10 | Growth EPS=+15.6% | Growth Revenue=+6.2%
EPS next Year (2028-01-31): EPS=4.06 | Chg7d=+0.262 | Chg30d=+0.277 | Revisions Net=+7 | Growth EPS=+17.1% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.1% (Discount Rate 15.8% - Earnings Yield 4.7%)
[Growth] Growth Spread = +1.8% (Analyst 12.9% - Implied 11.1%)
P/E Forward = 16.9492
P/S = 0.5495
P/B = 5.5143
Revenue TTM = 6.55b USD
EBIT TTM = 46.1m USD
EBITDA TTM = 460.1m USD
Long Term Debt = 1.35b USD (from longTermDebt, two quarters ago)
Short Term Debt = 288.0m USD (from shortTermDebt, two quarters ago)
Debt = 4.74b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 4.74b USD (using Total Debt 4.74b, CCE unavailable)
Enterprise Value = 8.34b USD (3.60b + Debt 4.74b - (null CCE))
Interest Coverage Ratio = 0.66 (Ebit TTM 46.1m / Interest Expense TTM 69.7m)
EV/FCF = 26.98x (Enterprise Value 8.34b / FCF TTM 309.0m)
FCF Yield = 3.71% (FCF TTM 309.0m / Enterprise Value 8.34b)
FCF Margin = 4.71% (FCF TTM 309.0m / Revenue TTM 6.55b)
Net Margin = 2.45% (Net Income TTM 160.9m / Revenue TTM 6.55b)
Gross Margin = 36.38% ((Revenue TTM 6.55b - Cost of Revenue TTM 4.17b) / Revenue TTM)
Gross Margin QoQ = 37.67% (prev 36.41%)
Tobins Q-Ratio = 1.62 (Enterprise Value 8.34b / Total Assets 5.13b)
Interest Expense / Debt = 0.35% (Interest Expense 16.8m / Debt 4.74b)
Taxrate = 7.42% (16.0m / 215.4m)
NOPAT = 42.7m (EBIT 46.1m * (1 - 7.42%))
Current Ratio = 1.30 (Total Current Assets 1.95b / Total Current Liabilities 1.49b)
Debt / Equity = 7.25 (Debt 4.74b / totalStockholderEquity, two quarters ago 653.0m)
Debt / EBITDA = 10.30 (Net Debt 4.74b / EBITDA 460.1m)
Debt / FCF = 15.33 (Net Debt 4.74b / FCF TTM 309.0m)
Total Stockholder Equity = 654.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.33% (Net Income 160.9m / Total Assets 5.13b)
RoE = 24.58% (Net Income TTM 160.9m / Total Stockholder Equity 654.5m)
RoCE = 2.30% (EBIT 46.1m / Capital Employed (Equity 654.5m + L.T.Debt 1.35b))
RoIC = 2.34% (NOPAT 42.7m / Invested Capital 1.82b)
WACC = 7.03% (E(3.60b)/V(8.34b) * Re(15.85%) + D(4.74b)/V(8.34b) * Rd(0.35%) * (1-Tc(0.07)))
Discount Rate = 15.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.25%
[DCF] Terminal Value 80.47% ; FCFF base≈248.6m ; Y1≈225.7m ; Y5≈197.0m
[DCF] Fair Price = N/A (negative equity: EV 4.34b - Net Debt 4.74b = -396.1m; debt exceeds intrinsic value)
EPS Correlation: -8.04 | EPS CAGR: 27.62% | SUE: 1.96 | # QB: 3
Revenue Correlation: 21.32 | Revenue CAGR: 12.00% | SUE: 1.36 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.32 | Chg7d=+0.232 | Chg30d=+0.232 | Revisions Net=+7 | Analysts=9
EPS current Year (2027-01-31): EPS=3.47 | Chg7d=+0.425 | Chg30d=+0.447 | Revisions Net=+10 | Growth EPS=+15.6% | Growth Revenue=+6.2%
EPS next Year (2028-01-31): EPS=4.06 | Chg7d=+0.262 | Chg30d=+0.277 | Revisions Net=+7 | Growth EPS=+17.1% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.1% (Discount Rate 15.8% - Earnings Yield 4.7%)
[Growth] Growth Spread = +1.8% (Analyst 12.9% - Implied 11.1%)